Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy.

Long-term survival after successful inhospital cardiac arrest resuscitation. Am Heart J (2007) 1.22

Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease. Br Heart J (1985) 1.18

Unexpected myocardial disease in patients with life threatening arrhythmias. Br Heart J (1986) 0.88

Diagnosis and management of ventricular tachycardia. Postgrad Med J (1992) 0.87

Out-of-hospital cardiac arrest in patients without clinically significant coronary artery disease: comparison of clinical, electrophysiological, and survival characteristics with those in similar patients who have clinically significant coronary artery disease. Br Heart J (1987) 0.84

Life threatening ventricular tachycardias in late survivors of surgically corrected tetralogy of Fallot. Br Heart J (1984) 0.81

Sudden cardiac death and acute coronary thrombosis. Br Med J (Clin Res Ed) (1985) 0.81

Who needs ventricular stimulation studies? Br Heart J (1994) 0.81

Clinical symptoms in patients with sustained ventricular tachycardia. West J Med (1985) 0.76

Non-contact mapping in the treatment of ventricular tachycardia after myocardial infarction. J Interv Card Electrophysiol (2007) 0.76

Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death. Basic Res Cardiol (1986) 0.75

Operative therapy of malignant ventricular rhythm disturbances. Ann Surg (1983) 0.75

Exercise in electrocardiography. Can Vet J (1991) 0.75

Newer antiarrhythmic drugs. West J Med (1981) 0.75

Recent trends in the management of life-threatening ventricular arrhythmias. West J Med (1984) 0.75

The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's. J Interv Card Electrophysiol (2000) 0.75

Secondary prevention of sudden death. J Interv Card Electrophysiol (2000) 0.75

[Holter monitoring and programmed ventricular stimulation]. Herzschrittmacherther Elektrophysiol (1997) 0.75

Changing concepts of electrophysiology testing for ventricular arrhythmias. J Interv Card Electrophysiol (2000) 0.75

Amiodarone: maximising survival benefit with empiric or guided therapy. J Interv Card Electrophysiol (2000) 0.75

A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31

Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med (1994) 4.00

Fish consumption and risk of sudden cardiac death. JAMA (1998) 3.06

Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97

Proteins of the human erythrocyte membrane as modified by pronase. J Mol Biol (1971) 2.51

Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) (1983) 2.43

Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J Biol Chem (1979) 2.23

The QT interval. Prog Cardiovasc Dis (2001) 2.22

Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation (1993) 2.20

Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol (1995) 2.14

Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation (1983) 2.05

Electrical alternans and cardiac electrical instability. Circulation (1988) 1.86

The evaluation and management of bradycardia. N Engl J Med (2000) 1.79

Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol (1990) 1.73

An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med (1981) 1.69

Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med (1988) 1.68

ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol (1999) 1.59

Sex differences in cardiac arrest survivors. Circulation (1996) 1.57

Sudden cardiac death: management of high-risk patients. Ann Intern Med (1991) 1.49

Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival. Heart (1998) 1.49

Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol (1989) 1.48

Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart (2004) 1.45

Adenosine and verapamil-sensitive ventricular tachycardia originating from the left ventricle: radiofrequency catheter ablation. Pacing Clin Electrophysiol (1992) 1.44

Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation (1986) 1.41

Hepatic mitochondrial function in ketogenic states. Diabetes, starvation, and after growth hormone administration. J Clin Invest (1975) 1.40

Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol (1991) 1.39

Regional wall motion analysis predicts survival and functional outcome after subendocardial resection in patients with prior anterior myocardial infarction. Circulation (1993) 1.38

Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol (1981) 1.26

An analysis of the cost effectiveness of the implantable defibrillator. Circulation (1990) 1.26

Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J (1995) 1.22

Effects of dispersive electrode position and surface area on electrical parameters and temperature during radiofrequency catheter ablation. Am J Cardiol (1996) 1.22

Basic aspects of radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1994) 1.22

A comparative analysis of antegrade and retrograde conduction patterns in man. Circulation (1975) 1.16

The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol (1988) 1.16

Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias. JAMA (1986) 1.13

Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med (1986) 1.11

ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). Circulation (1999) 1.11

Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med (1983) 1.11

Primary pulmonary hypertension treated with oral phentolamine. Ann Intern Med (1979) 1.10

Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation (1994) 1.09

The cardiac arrhythmia suppression trial (CAST). N Engl J Med (1989) 1.09

Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am J Cardiol (2001) 1.08

Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up. J Am Coll Cardiol (1990) 1.08

Demonstration of re-entry within the His-Purkinje system in man. Circulation (1974) 1.08

Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia. Circulation (1987) 1.08

The central nervous system as a site of action for the coronary vasoconstrictor effect of digoxin. J Clin Invest (1974) 1.07

Intracardiac electrophysiologic techniques in recurrent syncope of unknown case. Ann Intern Med (1981) 1.07

Asystole after exercise in healthy persons. Ann Intern Med (1994) 1.07

Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias. Ann Intern Med (1992) 1.05

Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol (1995) 1.05

Adenosine and the treatment of supraventricular tachycardia. Am J Med (1992) 1.03

Paroxysmal supraventricular tachycardia with Wenckebach block: evidence for reentry within the upper portion of the atrioventricular node. J Am Coll Cardiol (1984) 1.03

Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. Am J Cardiol (1984) 1.02

Repolarization inhomogeneities in ventricular myocardium change dynamically with abrupt cycle length shortening. Circulation (1991) 1.01

Electrophysiologic properties of flecainide acetate. Am J Cardiol (1984) 1.01

Postexercise peril. Plasma catecholamines and exercise. JAMA (1984) 1.01

The neurogenic vasoconstrictor effect of digitalis on coronary vascular resistance. J Clin Invest (1974) 1.01

The clinical course of palpitations in medical outpatients. Arch Intern Med (1995) 1.01

Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node. Circulation (1984) 1.00

Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Coll Cardiol (1994) 1.00

Usefulness of adenosine for arrhythmias in infants and children. Am J Cardiol (1988) 0.99

Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. J Am Coll Cardiol (2001) 0.99

Antegrade and retrograde conduction characteristics in three patterns of paroxysmal atrioventricular junctional reentrant tachycardia. Am Heart J (1978) 0.99

Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol (1995) 0.99

Transvenous cardioverter-defibrillator implantation via persistent left superior vena cava. Am Heart J (1995) 0.98

American College of Cardiology/American Heart Association clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion. A report of the American College of Cardiology/American Heart Association/American College of Physicians--American Society of Internal Medicine Task Force on clinical competence. J Am Coll Cardiol (2000) 0.97

Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators. North American Society of Electrophysiology and Pacing. Pacing Clin Electrophysiol (2001) 0.96

Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts. Circulation (1984) 0.95

Pseudo-pacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol (1993) 0.94

Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity. Circulation (1990) 0.93

Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity. J Am Coll Cardiol (1987) 0.93

Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med (1994) 0.92

Electrophysiologic characteristics of accessory atrioventricular connections in an inherited form of Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol (1999) 0.92

Endocardial, intramural, and epicardial activation patterns during sustained monomorphic ventricular tachycardia in late canine myocardial infarction. Circ Res (1987) 0.91

Idiopathic ventricular fibrillation: is there a role for electrophysiologic-guided antiarrhythmic drug therapy? J Cardiovasc Electrophysiol (1999) 0.91

Relation between shock-related myocardial injury and defibrillation efficacy of monophasic and biphasic shocks in a canine model. Circulation (1994) 0.90

Treatment strategies for atrial fibrillation. Am J Med (1998) 0.90